Feds tackle dialysis giants with antitrust probe
The Federal Trade Commission investigation of DaVita and Fresenius Medical Care follows years of consolidation in the dialysis industry.
Today's Liberal News
By Josh Sisco
Feds tackle dialysis giants with antitrust probe
The Federal Trade Commission investigation of DaVita and Fresenius Medical Care follows years of consolidation in the dialysis industry.
Feds tackle dialysis giants with antitrust probe
The Federal Trade Commission investigation of DaVita and Fresenius Medical Care follows years of consolidation in the dialysis industry.
Feds poised to sue pharmacy gatekeepers over high drug costs
The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.
Feds tackle dialysis giants with antitrust probe
The Federal Trade Commission investigation of DaVita and Fresenius Medical Care follows years of consolidation in the dialysis industry.
Feds poised to sue pharmacy gatekeepers over high drug costs
The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.
Feds tackle dialysis giants with antitrust probe
The Federal Trade Commission investigation of DaVita and Fresenius Medical Care follows years of consolidation in the dialysis industry.
Feds poised to sue pharmacy gatekeepers over high drug costs
The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.
Feds tackle dialysis giants with antitrust probe
The Federal Trade Commission investigation of DaVita and Fresenius Medical Care follows years of consolidation in the dialysis industry.
Feds poised to sue pharmacy gatekeepers over high drug costs
The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.
Feds tackle dialysis giants with antitrust probe
The Federal Trade Commission investigation of DaVita and Fresenius Medical Care follows years of consolidation in the dialysis industry.
Feds poised to sue pharmacy gatekeepers over high drug costs
The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.
Feds tackle dialysis giants with antitrust probe
The Federal Trade Commission investigation of DaVita and Fresenius Medical Care follows years of consolidation in the dialysis industry.
Feds poised to sue pharmacy gatekeepers over high drug costs
The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.
Feds tackle dialysis giants with antitrust probe
The Federal Trade Commission investigation of DaVita and Fresenius Medical Care follows years of consolidation in the dialysis industry.
Feds poised to sue pharmacy gatekeepers over high drug costs
The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.
Feds tackle dialysis giants with antitrust probe
The Federal Trade Commission investigation of DaVita and Fresenius Medical Care follows years of consolidation in the dialysis industry.
Feds poised to sue pharmacy gatekeepers over high drug costs
The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.
Feds tackle dialysis giants with antitrust probe
The Federal Trade Commission investigation of DaVita and Fresenius Medical Care follows years of consolidation in the dialysis industry.
Feds poised to sue pharmacy gatekeepers over high drug costs
The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.
Feds tackle dialysis giants with antitrust probe
The Federal Trade Commission investigation of DaVita and Fresenius Medical Care follows years of consolidation in the dialysis industry.
Feds poised to sue pharmacy gatekeepers over high drug costs
The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.
Feds poised to sue pharmacy gatekeepers over high drug costs
The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.
Feds tackle dialysis giants with antitrust probe
The Federal Trade Commission investigation of DaVita and Fresenius Medical Care follows years of consolidation in the dialysis industry.
Feds tackle dialysis giants with antitrust probe
The Federal Trade Commission investigation of DaVita and Fresenius Medical Care follows years of consolidation in the dialysis industry.
Feds poised to sue pharmacy gatekeepers over high drug costs
The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.
Feds tackle dialysis giants with antitrust probe
The Federal Trade Commission investigation of DaVita and Fresenius Medical Care follows years of consolidation in the dialysis industry.
Feds poised to sue pharmacy gatekeepers over high drug costs
The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.
Feds tackle dialysis giants with antitrust probe
The Federal Trade Commission investigation of DaVita and Fresenius Medical Care follows years of consolidation in the dialysis industry.
Feds poised to sue pharmacy gatekeepers over high drug costs
The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.